The focal adhesion kinase inhibitor BI853520 inhibits the proliferation, migration, invasion and epithelial-mesenchymal transition of cancer cells by affecting the PI3K/AKT/mTOR signaling pathway (Zhang et al., 2020; Li et al., 2021). This evidence concerns the gene AKT1 and cancer.